Prevention · Screening · Early detection
Lung Cancer Screening in High-Risk Individuals
Low-dose CT can reduce lung cancer deaths in selected high-risk people. It is not an annual scan for everyone.
Chapter 11 of 16
Choose a chapter
Key facts
- LDCT screening is for eligible people without lung-cancer symptoms.
- A chest X-ray is not an equivalent screening test.
- Smoking cessation remains essential whether or not screening is offered.
Recommendations at a glance
These are guideline comparisons, not a personalised prescription. Symptoms and high-risk history take priority over routine screening schedules.
| Guideline / group | Age or eligibility | Test / interval | Important limitation |
|---|---|---|---|
| USPSTF 2021 | 50–80; at least 20 cigarette pack-years | Annual LDCT; current smoking or quit within 15 years | Stop when quit threshold or health stopping criteria apply |
| ACS 2023 | 50–80; at least 20 cigarette pack-years | Annual LDCT; no years-since-quitting exclusion | Health and ability/willingness for treatment matter |
| Symptoms or non-cigarette exposure | Any age | Clinical assessment | Calculator does not establish eligibility |
Choose the right next step
- New or concerning symptoms? Arrange diagnostic assessment. Severe bleeding, breathlessness or new neurological weakness needs urgent care.
- No symptoms, but previous cancer, precancer or increased inherited risk? Ask for an individual surveillance plan; average-risk intervals may not apply.
- No such history? Use this chapter to discuss prevention and, where appropriate, age- and test-specific screening. Lifestyle exposures alone do not establish eligibility for every test.
- After testing: Collect the result, complete any referral, and record the next review date. A normal screen does not explain a later symptom.
USPSTF eligibility
The 2021 USPSTF grade B recommendation is annual low-dose CT at ages 50–80 with at least 20 cigarette pack-years, for current smokers or people who quit within the previous 15 years. Stop once 15 years have elapsed since quitting, or if health substantially limits life expectancy or ability or willingness to undergo curative lung surgery. Eligibility must be reviewed by the screening service, including willingness for follow-up.
ACS uses different former-smoker criteria
ACS 2023 also recommends annual LDCT for eligible adults 50–80 with at least 20 pack-years, but does not use years since quitting to exclude former smokers. Severe illness or inability or unwillingness to receive treatment can make screening inappropriate. The difference should be explained rather than blending both organisations into a single rule.
Understanding pack-years
Pack-years equal cigarettes per day divided by 20, multiplied by years smoked. Ten cigarettes daily for 40 years equals 20 pack-years. If intensity changed, calculate each period and add the results. This is an exposure measure, not a cancer probability. There is no reliable universal conversion from bidis, hookah, smokeless tobacco or mixed products into cigarette pack-years for these eligibility rules.
Benefits and downstream harms
LDCT can find smaller cancers, but also benign nodules and unrelated abnormalities. Some findings lead to repeat scans, invasive procedures, anxiety or overdiagnosis. Radiation per low-dose scan is lower than routine diagnostic CT but cumulative exposure still matters. A nodule is not automatically cancer. Consistent reporting and a defined nodule-management pathway reduce avoidable harm.
Screening quality and Indian context
Choose a programme with appropriate low-dose protocols, experienced interpretation, comparison with prior images and access to follow-up. Indian smoking patterns, bidi exposure, tuberculosis-related scars, background risk and resource availability complicate direct application of US criteria. Specialist assessment may be appropriate when cigarette-based criteria do not describe the exposure, but annual LDCT should not be offered to every person with any exposure.
Symptoms require a different route
Coughing blood, persistent progressive cough, unexplained weight loss, chest pain or breathlessness require clinical evaluation. Do not wait until you meet screening age or request a low-dose screening scan as a substitute for a diagnostic pathway. Quitting smoking improves health even if a person already qualifies for screening; a normal scan is not permission to continue.
Practical steps
- Bring a detailed smoking timeline and quit date.
- Ask which guideline and nodule follow-up protocol the service uses.
- Combine screening with cessation support.
Myth and fact
A normal annual CT makes smoking safe.
False. Screening does not prevent all lung cancers or the other harms of tobacco.
Frequently asked questions
I quit 20 years ago; am I automatically excluded?
USPSTF and ACS differ. Discuss your age, pack-years, health and the programme’s guideline.
Can a bidi smoker use the cigarette calculator?
It cannot provide a validated conversion; discuss the actual exposure with a clinician.
Continue learning
Sources and guideline context
- USPSTF — Lung cancer screening
9 March 2021; B recommendation
- ACS — Lung screening guideline
2023 update
- WHO — Tobacco cessation guideline
2 July 2024